This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Rao JK et al. (1995) The role of antineutrophil cytoplasmatic antibody (c-ANCA) testing in the diagnosis of Wegener granulomatosis. A literature review and meta-analysis. Ann Intern Med 123: 925–932
Hagen EC et al. (1998) Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Kidney Int 53: 743–753
Han WK et al. (2003) Serial ANCA titers: useful tool for prevention of relapses in ANCA associated vasculitis. Kidney Int 63: 1079–1085
Savige J et al. (1999) International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA). Am J Clin Pathol 111: 507–513
Holle JU et al. (2005) Variations in performance characteristics of commercial enzyme immunoassay kits of the detection of antineutrophil cytoplasmatic antibodies: what is the optimal cut-off? Ann Rheum Dis 64: 1773–1779
Csernok E et al. (2004) Evaluation of capture ELISA for detection of neutrophil cytoplasmatic antibodies directed against proteinase 3 in Wegener's granulomatosis: first results from a multicentre study. Rheumatology (Oxford) 43: 174–180
Franssen C et al. (1998) Disease spectrum of patients with antineutrophil cytoplasmic autoantibodies of defined specificity: distinct differences between patients with anti-proteinase 3 and anti-myeloperoxidase autoantibodies. J Intern Med 244: 209–216
Schönermarck U et al. (2001) Prevalence and spectrum of rheumatic diseases associated with proteinase 3-antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase-ANCA. Rheumatology (Oxford) 40: 178–184
Hauer HA et al. (2002) Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups. Kidney Int 61: 80–89
Sinclair D et al. (2004) The effect of a symptom related "gating" policy on ANCA requests in routine clinical practice. J Clin Pathol 57: 131–134
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Csernok, E., Lamprecht, P. & Gross, W. Diagnostic significance of ANCA in vasculitis. Nat Rev Rheumatol 2, 174–175 (2006). https://doi.org/10.1038/ncprheum0159
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncprheum0159
This article is cited by
-
ANCA-Diagnostik bei Vaskulitiden
Zeitschrift für Rheumatologie (2020)
-
Renal-limited vasculitis with elevated levels of multiple antibodies
CEN Case Reports (2017)
-
Autoantibodies and their Judicious Use in Pediatric Rheumatology Practice
The Indian Journal of Pediatrics (2016)
-
Current and emerging techniques for ANCA detection in vasculitis
Nature Reviews Rheumatology (2014)
-
ANCA testing: the current stage and perspectives
Clinical and Experimental Nephrology (2013)